CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net income	$ 3,251	$ 4,506
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	968	995
Amortization on right-of-use assets	953	819
Provision (Recovery) for bad debts	2,227	(239)
Stock issued for costs and expense		1,991
Deferred income tax - net	849	1,004
Abandoned patents	1
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(4,109)	(1,188)
Notes receivable	14
Costs and estimated earnings in excess of billings on uncompleted contracts		218
Inventories	(49)	7
Income tax receivable	671
Prepaid expenses and other current assets	(125)	233
Other assets		(44)
Increase (decrease) in operating liabilities, net:
Accounts payable	(117)	(345)
Other current liabilities	(36)	(2,889)
Operating lease liabilities	(796)	(750)
Financing lease liability	12
Customer advances	58	(62)
Other liabilities	10	(13)
Net cash provided by operating activities	3,782	4,243
Cash Flows from Investing Activities:
Purchases of property and equipment	(415)	(2,411)
Purchase of short term investment		(119)
Cost of patents	(20)	(38)
Net cash used in investing activities	(435)	(2,568)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(9)	(8)
Proceeds from debt	63
Distributions to noncontrolling interests	(1,440)	(1,755)
Net cash used in financing activities	(1,386)	(1,763)
Net Increase (decrease) in Cash and Cash Equivalents	1,961	(88)
Cash and Cash Equivalents - Beginning of Period	36,802	13,882
Cash and Cash Equivalents - End of Period	$ 38,763	$ 13,794